Genetic Alteration of a Bispecific Ligand-Directed Toxin Targeting Human CD19 and CD22 Receptors Resulting in Improved Efficacy Against Systemic B Cell Malignancy
Leukemia Research - United Kingdom
doi 10.1016/j.leukres.2009.02.006
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 2009
Authors
Publisher
Elsevier BV